Dexmedetomidine protects the uterus against ischemia-reperfusion injury in rats      
Yazarlar (8)
Dr. Öğr. Üyesi Vildan KÖLÜKÇÜ Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Dr. Öğr. Üyesi Mehtap GÜRLER BALTA Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Prof. Dr. Hakan TAPAR Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Prof. Dr. Tuğba KARAMAN Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Prof. Dr. Serkan KARAMAN Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Velid Unsal
Mardin Artuklu University, Türkiye
Prof. Dr. Fikret GEVREK Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Doç. Dr. Muzaffer KATAR Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Makale Türü Özgün Makale
Makale Alt Türü SCOPUS dergilerinde yayınlanan tam makale
Dergi Adı European Review for Medical and Pharmacological Sciences
Dergi ISSN 1128-3602 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI
Makale Dili İngilizce
Basım Tarihi 03-2024
Cilt No 28
Sayı 6
Sayfalar 2501 / 2508
DOI Numarası 10.26355/eurrev_202403_35757
Makale Linki https://www.europeanreview.org/wp/wp-content/uploads/2501-2508.pdf
Özet
OBJECTIVE: This study aimed to analyze the histopathological and biochemical effects of dexmedetomidine on the rat uteri exposed to experimental ischemia-reperfusion injury. MATERIALS AND METHODS: Twenty-four female rats were randomly divided into three groups. Group 1 was defined as the control group. An experimental uterine ischemia-reperfusion model was created in Group 2. Group 3 was assigned as the treatment group. Similar uterine ischemia-reperfusion models were created for the rats in Group 3, and then, unlike the other groups, 100 μg/kg of dexmedetomidine was administered intraperitoneally immediately after the onset of reperfusion. In blood biochemical analysis, superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) activities and malondialdehyde (MDA), interleukin 1beta (IL-1β), interleukin 6 (IL-6) and tumor necrosis factor-alpha (TNF-α) levels were measured. In the histopathological analyses, endometrial epithelial glandular changes (leukocytosis, cell degeneration) and endometrial stromal changes (congestion, edema) were analyzed using the tissue damage scoring system. RESULTS: It was observed that IL-1β, IL-6, and TNF-α levels were significantly suppressed in Group 3 compared to Group 2 (p= 0.001, p< 0.001 and p= 0.001, respectively). MDA level was noted as the highest in Group 2. The MDA value in Group 3 was measured at 5.37±0.82, which was significantly decreased compared to Group 2 (p< 0.001). An increase in antioxidant enzyme activities (SOD and GSH-PX) was observed in Group 3 compared to Group 2 (p= 0.001 and p= 0.006, respectively). In our histopathological analysis, a …
Anahtar Kelimeler
Dexmedetomidine | Oxidative damage | Uterus
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
SCOPUS 1
Google Scholar 2
Dexmedetomidine protects the uterus against ischemia-reperfusion injury in rats

Paylaş